查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828219

2025年粒子治疗全球市场报告

Particle Therapy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，粒子治疗市场规模迅速扩张，从2024年的12.3亿美元成长到2025年的13.6亿美元，复合年增长率达11.0%。这段历史时期的成长可归因于临床研究和调查、癌症发生率的上升、政府支持和资金投入、产业合作以及治疗方案的改进。

预计未来几年粒子治疗市场规模将快速成长，到2029年将达到21.6亿美元，复合年增长率为12.3%。预测期内的增长可归因于医疗保健支出的增加、新兴的非肿瘤学应用、老年人口的增长、医疗保健基础设施的发展以及人工智慧和数据分析的融合。预测期内的主要趋势包括粒子加速器技术的进步、低分次技术、联合治疗、患者舒适度的提高以及生物主导的治疗通讯协定。

粒子治疗是一种先进的癌症治疗方法，它利用带电粒子（例如质子和重离子）将放射治疗直接传送到癌症肿瘤。这种治疗方法主要利用高能量电离粒子瞄准肿瘤部位，旨在改善各种肿瘤患者的预后，尤其是那些难以用常规放射疗法治疗的肿瘤患者。

粒子治疗治疗方法分为两种：质子治疗和重离子治疗。质子治疗是一种专门用于癌症治疗的放射治疗。质子治疗适用于单室和多室系统，应用范围广泛。质子治疗可用于治疗多种癌症，包括但不限于儿童癌症、摄护腺癌、肺癌、乳癌以及脑部和脊髓癌。粒子治疗的主要终端使用者是医院、学术机构和研究中心。粒子治疗为癌症治疗提供了一种有针对性的精准方法，最大限度地减少了对周围健康组织的损伤，并增强了放射治疗的效果。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供粒子治疗市场统计数据，例如粒子治疗行业的全球市场规模、各地区市场份额、各竞争对手的市场份额、详细的粒子治疗细分市场、市场趋势和商业机会，以及在粒子治疗行业取得成功所需的数据。本粒子治疗市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的全方位观点。

未来五年的预测成长率为12.3%，较我们先前对该市场的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国，因为超导性迴旋加速器磁铁和束流引导系统（主要由比利时和义大利供应）的成本上升，从而影响美国先进的癌症治疗中心的运作。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，这种影响也将更加广泛。

癌症发生率的上升预计将推动未来粒子治疗市场的成长。癌症是一类复杂多样的疾病，其特征是体内细胞的异常生长和增生。粒子治疗透过将带正电的粒子（质子）加速到高速，聚焦于肿瘤并进行精确的放射治疗，从而有效地治疗癌症。例如，总部位于法国的政府间组织国际癌症研究机构（IARC）于2024年4月报告称，2022年全球将新增约2,000万例癌症病例，约1,000万人死亡。根据人口趋势预测，到2050年，全球新增癌症病例可能达到每年3,500万例，比2022年增加77%。因此，癌症发生率的上升是推动粒子治疗市场成长的关键因素。

预计人口老化将在未来几年推动粒子治疗市场的成长。老化是指社会中老年人比例不断增加的人口结构变化。粒子治疗对老年人尤其有益，因为它可以精准、有针对性地治疗癌症，最大限度地减少对周围健康组织的损害，降低长期副作用的风险，从而提高接受癌症治疗的老年患者的生活品质。例如，总部位于肯亚的非营利人口研究所在2024年1月估计，到2050年，65岁及以上的美国人口数量将增加47%，从2022年的5,800万增加到8,200万人。预计同期该年龄层人口占总人口的比例也将从17%增加到23%。因此，老化是粒子治疗市场的主要驱动力。

先进的粒子治疗平台正成为粒子治疗市场的关键趋势。该领域的主要参与者正致力于开发创新的粒子治疗解决方案，以保持竞争力。例如，2023年7月，瑞典医疗科技公司RaySearch Laboratories推出了RayStation 2023B。这款全面的肿瘤治疗计划系统融合了粒子治疗领域的多项突破性进展，包括支持离散质子弧和基于线性能量转移（LET）的稳健优化。 LET优化旨在透过将高LET粒子靶向肿瘤，从而最大限度地减少潜在的副作用，从而改善肿瘤控制，同时降低危及器官的LET。此外，离散质子弧优化可实现更大的射束角度范围，从而实现更适形的剂量分布，并减少敏感器官的暴露。该软体还可以轻鬆转换为标准笔射束扫描计划，为光子治疗提供自动化的场内规划，为近距离放射治疗提供基于点的优化，并加快数据加载速度。

为了获得竞争优势，粒子治疗市场的主要企业正在加紧努力开发创新治疗方法，尤其是质子治疗解决方案。质子治疗技术是一种先进的癌症治疗方法，它利用质子和带正电的粒子向癌细胞提供精确的标靶辐射。例如，2023 年 4 月，以色列高科技公司 P-Cure 的自适应质子治疗解决方案获得美国食品药物管理局(USFDA) 的批准，允许其在美国销售。这种经济实惠的质子治疗技术旨在进行标靶癌症治疗，并显着减少与治疗相关的副作用。 P-Cure 的创新直立解决方案是世界上第一个获得 FDA核准的患者定位技术，可在坐姿下进行治疗，从而提高患者的舒适度和临床效果。

2022年5月，总部位于德国的医疗科技公司Brainlab AG收购了medPhoton GmbH的多数股权，收购金额未揭露。此次策略性收购旨在扩展Brainlab的术中成像产品组合，推动业务成长，加强产品开发，并加速这一重要医疗技术领域的创新。 medPhoton GmbH是一家总部位于奥地利的医疗设备製造商，专门提供粒子束治疗设备和服务。

粒子治疗市场涵盖提供粒子治疗服务的营业单位所获得的收益，这些服务包括治疗计划、粒子输送、成像和模拟、治疗疗程、病患监测以及支援服务。市场价值还包括服务提供者销售或包含在服务产品中的相关商品的价值。仅包括营业单位之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球粒子疗法：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球粒子治疗市场：成长率分析
  • 全球粒子治疗市场表现：规模与成长，2019-2024
  • 全球粒子治疗市场预测：规模与成长，2024-2029年，2034年
  • 全球粒子治疗：总目标市场（TAM）

第六章 市场细分

  • 全球粒子治疗市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 质子治疗
  • 重粒子线治疗
  • 全球粒子治疗市场：按系统、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 单室系统
  • 多房间系统
  • 全球粒子治疗市场（按癌症类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 儿童癌症
  • 摄护腺癌
  • 肺癌
  • 乳癌
  • 脑癌和脊髓癌
  • 其他类型的癌症
  • 全球粒子治疗市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 学术研究中心
  • 全球粒子治疗市场：依质子治疗类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 笔射束扫描质子治疗
  • 被动散射质子治疗
  • 调强质子治疗（IMPT）
  • 全球粒子治疗市场：重离子治疗细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 碳离子疗法
  • 氦离子疗法
  • 其他重离子

第七章 区域和国家分析

  • 全球粒子治疗市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球粒子治疗市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 粒子束治疗市场：竞争格局
  • 粒子治疗市场：公司简介
    • Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Mitsubishi Electric Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems Inc.
  • Elekta AB
  • Shinva Medical Instrument Co. Ltd.
  • Toshiba Medical Systems Corporation
  • Brainlab AG
  • Accuray Incorporated
  • IBA Worldwide
  • Mevion Medical Systems Inc.
  • Avante Health Solutions
  • Provision Healthcare LLC
  • ViewRay
  • Panacea Biotec Ltd.
  • PTW Freiburg GmbH.
  • ProNova Solutions LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年粒子治疗市场：提供新机会的国家
  • 2029年粒子治疗市场：细分领域带来新机会
  • 2029年粒子治疗市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25184u

Particle therapy is an advanced cancer treatment that employs charged particles, such as protons or heavier ions, to administer radiation therapy directly to cancerous tumors. This method primarily targets energetic ionizing particles at the tumor location, aiming to improve treatment outcomes for patients with various types of tumors, particularly those that are difficult to treat using conventional radiation therapy.

Two primary types of therapies fall under the umbrella of particle therapy, proton therapy and heavy ion therapy. Proton therapy is a specialized form of radiation therapy employed in cancer treatment. It encompasses both single-room systems and multi-room systems, providing versatility in its application. Proton therapy is utilized for the treatment of various cancers, including but not limited to pediatric cancer, prostate cancer, lung cancer, breast cancer, and cancers affecting the brain and spinal cord. The primary end users of particle therapy are hospitals, academic institutions, and research centers. Particle therapy offers a targeted and precise approach to cancer treatment, minimizing damage to surrounding healthy tissues and enhancing the therapeutic effectiveness of radiation.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The particle therapy market research report is one of a series of new reports from The Business Research Company that provides particle therapy market statistics, including particle therapy industry global market size, regional shares, competitors with a particle therapy market share, detailed particle therapy market segments, market trends and opportunities, and any further data you may need to thrive in the particle therapy industry. This particle therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The particle therapy market size has grown rapidly in recent years. It will grow from $1.23 billion in 2024 to $1.36 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to clinical research and studies, increased cancer incidence, government support and funding, industry collaboration, and improvements in treatment planning.

The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $2.16 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing healthcare expenditure, emerging applications beyond cancer, a rise in the geriatric population, healthcare infrastructure development, AI and data analytics integration. Major trends in the forecast period include advancements in particle accelerator technology, hypofractionation techniques, proton and carbon ion combination therapy, improved patient comfort, and biology-driven treatment protocols.

The forecast of 12.3% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher costs for superconducting cyclotron magnets and beam guidance systems, predominantly supplied by Belgium and Italy, impacting advanced cancer treatment center operations.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cancer is anticipated to drive the growth of the particle therapy market in the future. Cancer is a complex and varied group of diseases marked by the abnormal growth and multiplication of cells in the body. Particle therapy effectively treats cancer through precise radiation delivery, utilizing positively charged particles (protons) that are accelerated to high speeds and focused on the tumor. For instance, in April 2024, the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, reported that nearly 20 million new cancer cases were recorded in 2022, resulting in almost 10 million deaths. Projections based on demographic trends indicate that the annual incidence of new cancer cases could reach 35 million by 2050, representing a 77% increase from the 2022 figures. Therefore, the rising prevalence of cancer is a key factor driving the growth of the particle therapy market.

The increasing aging population is projected to contribute to the growth of the particle therapy market in the coming years. An aging population refers to a demographic shift characterized by a growing proportion of elderly individuals within a society. Particle therapy is particularly beneficial for the geriatric population as it offers a precise and targeted approach to cancer treatment, minimizing damage to surrounding healthy tissues and reducing the risk of long-term side effects, thereby enhancing the quality of life for older patients receiving cancer therapy. For example, in January 2024, the Population Reference Bureau, a Kenya-based nonprofit organization, estimated that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. This age group's share of the total population is also expected to grow from 17% to 23% during the same period. Thus, the aging population is a significant driver of the particle therapy market.

Advanced particle therapy platforms are becoming a significant trend in the particle therapy market. Key players in this field are focusing on developing innovative particle therapy solutions to maintain their competitive edge. For example, in July 2023, RaySearch Laboratories, a Sweden-based medical technology firm, introduced RayStation 2023B. This comprehensive oncology treatment planning system incorporates several groundbreaking advancements in particle therapy, including support for discrete proton arcs and robust optimization based on linear energy transfer (LET). LET optimization aims to minimize potential side effects by reducing LET in at-risk organs while directing high LET particles to tumors for better tumor control. Additionally, discrete proton arc optimization allows for a wider range of beam angles, resulting in more conformal dose distributions and less exposure for sensitive organs. The software also offers easy conversion to standard pencil-beam scanning plans, automatic field-in-field planning for photon treatments, point-based optimization for brachytherapy, and improved data loading speeds.

Key companies in the particle therapy market are intensifying their efforts to develop innovative therapies, with a particular focus on proton therapy solutions, to gain a competitive advantage. Proton therapy technology, a sophisticated form of cancer treatment utilizing protons and positively charged particles, delivers precise and targeted radiation to cancer cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech company, obtained clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing sales in the USA. This affordable proton therapy technology is designed for targeted cancer treatment with significantly reduced treatment-related side effects. P-Cure's innovative upright solution, the world's first FDA-approved methodology for patient positioning, enables seated treatment, enhancing both patient comfort and clinical outcomes.

In May 2022, Brainlab AG, a Germany-based medical technology company, acquired a majority stake in medPhoton GmbH for an undisclosed amount. This strategic acquisition aims to expand Brainlab's intraoperative imaging portfolio, drive business growth, bolster product development, and accelerate innovation in the critical field of medical technology. medPhoton GmbH, an Austria-based medical equipment manufacturing company, specializes in providing particle therapy devices and services.

Major companies operating in the particle therapy market include Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the particle therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The particle therapy market includes of revenues earned by entities by providing particle therapy services such as treatment planning, particle beam delivery, imaging and simulation, treatment sessions, patient monitoring, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Particle Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on particle therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for particle therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The particle therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Proton Therapy; Heavy Ion Therapy
  • 2) By System: Single-Room Systems; Multi-Room Systems
  • 3) By Cancer Type: Pediatric Cancer; Prostate Cancer; Lung Cancer; Breast Cancer; Brain And Spinal Cord Cancer; Other Cancer Types
  • 4) By End-User: Hospital; Academic And Research Centers
  • Subsegments:
  • 1) By Proton Therapy: Pencil Beam Scanning Proton Therapy; Passive Scattering Proton Therapy; Intensity-Modulated Proton Therapy (IMPT)
  • 2) By Heavy Ion Therapy: Carbon Ion Therapy; Helium Ion Therapy; Other Heavy Ions
  • Companies Mentioned: Hitachi Ltd.; Mitsubishi Electric Corporation; Siemens Healthineers AG; Koninklijke Philips N.V; GE Healthcare; Sumitomo Heavy Industries Ltd.; Varian Medical Systems Inc.; Elekta AB; Shinva Medical Instrument Co. Ltd.; Toshiba Medical Systems Corporation; Brainlab AG; Accuray Incorporated; IBA Worldwide; Mevion Medical Systems Inc.; Avante Health Solutions; Provision Healthcare LLC; ViewRay; Panacea Biotec Ltd.; PTW Freiburg GmbH.; ProNova Solutions LLC; Optivus Proton Therapy Inc.; Xstrahl Inc.; Protom International Inc.; Danfysik AS; SAH Global LLC; Advanced Oncotherapy plc; Particle Therapy Co-Operative Group; Best Particle Therapy Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Particle Therapy Market Characteristics

3. Particle Therapy Market Trends And Strategies

4. Particle Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Particle Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Particle Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Particle Therapy Market Growth Rate Analysis
  • 5.4. Global Particle Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Particle Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Particle Therapy Total Addressable Market (TAM)

6. Particle Therapy Market Segmentation

  • 6.1. Global Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Proton Therapy
  • Heavy Ion Therapy
  • 6.2. Global Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Room Systems
  • Multi-Room Systems
  • 6.3. Global Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pediatric Cancer
  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Brain And Spinal Cord Cancer
  • Other Cancer Types
  • 6.4. Global Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Academic And Research Centers
  • 6.5. Global Particle Therapy Market, Sub-Segmentation Of Proton Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pencil Beam Scanning Proton Therapy
  • Passive Scattering Proton Therapy
  • Intensity-Modulated Proton Therapy (IMPT)
  • 6.6. Global Particle Therapy Market, Sub-Segmentation Of Heavy Ion Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Carbon Ion Therapy
  • Helium Ion Therapy
  • Other Heavy Ions

7. Particle Therapy Market Regional And Country Analysis

  • 7.1. Global Particle Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Particle Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Particle Therapy Market

  • 8.1. Asia-Pacific Particle Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Particle Therapy Market

  • 9.1. China Particle Therapy Market Overview
  • 9.2. China Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Particle Therapy Market

  • 10.1. India Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Particle Therapy Market

  • 11.1. Japan Particle Therapy Market Overview
  • 11.2. Japan Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Particle Therapy Market

  • 12.1. Australia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Particle Therapy Market

  • 13.1. Indonesia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Particle Therapy Market

  • 14.1. South Korea Particle Therapy Market Overview
  • 14.2. South Korea Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Particle Therapy Market

  • 15.1. Western Europe Particle Therapy Market Overview
  • 15.2. Western Europe Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Particle Therapy Market

  • 16.1. UK Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Particle Therapy Market

  • 17.1. Germany Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Particle Therapy Market

  • 18.1. France Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Particle Therapy Market

  • 19.1. Italy Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Particle Therapy Market

  • 20.1. Spain Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Particle Therapy Market

  • 21.1. Eastern Europe Particle Therapy Market Overview
  • 21.2. Eastern Europe Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Particle Therapy Market

  • 22.1. Russia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Particle Therapy Market

  • 23.1. North America Particle Therapy Market Overview
  • 23.2. North America Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Particle Therapy Market

  • 24.1. USA Particle Therapy Market Overview
  • 24.2. USA Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Particle Therapy Market

  • 25.1. Canada Particle Therapy Market Overview
  • 25.2. Canada Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Particle Therapy Market

  • 26.1. South America Particle Therapy Market Overview
  • 26.2. South America Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Particle Therapy Market

  • 27.1. Brazil Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Particle Therapy Market

  • 28.1. Middle East Particle Therapy Market Overview
  • 28.2. Middle East Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Particle Therapy Market

  • 29.1. Africa Particle Therapy Market Overview
  • 29.2. Africa Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Particle Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Particle Therapy Market Competitive Landscape
  • 30.2. Particle Therapy Market Company Profiles
    • 30.2.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Mitsubishi Electric Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

31. Particle Therapy Market Other Major And Innovative Companies

  • 31.1. Sumitomo Heavy Industries Ltd.
  • 31.2. Varian Medical Systems Inc.
  • 31.3. Elekta AB
  • 31.4. Shinva Medical Instrument Co. Ltd.
  • 31.5. Toshiba Medical Systems Corporation
  • 31.6. Brainlab AG
  • 31.7. Accuray Incorporated
  • 31.8. IBA Worldwide
  • 31.9. Mevion Medical Systems Inc.
  • 31.10. Avante Health Solutions
  • 31.11. Provision Healthcare LLC
  • 31.12. ViewRay
  • 31.13. Panacea Biotec Ltd.
  • 31.14. PTW Freiburg GmbH.
  • 31.15. ProNova Solutions LLC

32. Global Particle Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Particle Therapy Market

34. Recent Developments In The Particle Therapy Market

35. Particle Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Particle Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Particle Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Particle Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer